SOAR Corporation is a licensed substance use treatment provider in Philadelphia, PA, listed in the SAMHSA treatment directory. An intensive outpatient program lets clients attend structured treatment several days a week while living at home. Methadone is available as part of medication assisted treatment for opioid use disorder. Buprenorphine (Suboxone) is offered to reduce opioid cravings and lower relapse and overdose risk. The program treats co-occurring mental health conditions alongside addiction. The facility reports accepting Medicaid. Private health insurance is accepted. It serves young adults, adults, seniors.
Availability and current services change often. Call (888) 470-5244
and we will help you confirm openings, insurance, and next steps.
Levels of care
OutpatientIntensive outpatient treatmentOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatment
Type of care
Substance use treatment
Medications
Methadone used in TreatmentBuprenorphine used in Treatment
Payment accepted
MedicareMedicaidPrivate health insuranceState-financed health insurance plan other than Medicaid
Ages served
Young AdultsAdultsSeniors
Accreditation
State substance use treatment agencyState department of healthCommission on Accreditation of Rehabilitation Facilities (CARF)SAMHSA certification for opioid treatment program (OTP)Drug Enforcement Agency (DEA)
Free & confidential, 24/7
Not sure which program fits? Talk it through with someone who can help.
Hospital inpatient/24-hour hospital inpatientResidential/24-hour residentialHospital inpatient treatmentFederal, or any government funding for substance use treatment programsMedicaid